IRIS
ABBADESSA, GIANMARCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 3.889
AS - Asia 1.874
NA - Nord America 1.461
SA - Sud America 314
AF - Africa 36
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 7.577
Salva come PNG Salva come JPEG
Nazione #
RU - Federazione Russa 3.036
US - Stati Uniti d'America 1.415
SG - Singapore 596
CN - Cina 451
IE - Irlanda 271
VN - Vietnam 271
HK - Hong Kong 260
BR - Brasile 248
IT - Italia 195
DE - Germania 130
KR - Corea 105
GB - Regno Unito 83
IN - India 77
JP - Giappone 41
AR - Argentina 28
FI - Finlandia 24
MX - Messico 20
FR - Francia 19
CA - Canada 18
SE - Svezia 18
UA - Ucraina 18
AT - Austria 14
EC - Ecuador 14
GR - Grecia 13
NL - Olanda 13
PL - Polonia 13
ID - Indonesia 10
IQ - Iraq 10
MA - Marocco 10
TR - Turchia 10
CZ - Repubblica Ceca 9
BE - Belgio 8
BD - Bangladesh 6
EG - Egitto 6
IL - Israele 6
VE - Venezuela 6
CO - Colombia 5
PK - Pakistan 5
CH - Svizzera 4
CL - Cile 4
ES - Italia 4
TN - Tunisia 4
UZ - Uzbekistan 4
ZA - Sudafrica 4
AE - Emirati Arabi Uniti 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
JO - Giordania 3
KE - Kenya 3
PE - Perù 3
PY - Paraguay 3
RS - Serbia 3
UY - Uruguay 3
BH - Bahrain 2
ET - Etiopia 2
HR - Croazia 2
KG - Kirghizistan 2
KZ - Kazakistan 2
LB - Libano 2
LU - Lussemburgo 2
NG - Nigeria 2
PA - Panama 2
PT - Portogallo 2
SA - Arabia Saudita 2
AL - Albania 1
AM - Armenia 1
AU - Australia 1
AZ - Azerbaigian 1
BY - Bielorussia 1
CG - Congo 1
DK - Danimarca 1
EU - Europa 1
HN - Honduras 1
HU - Ungheria 1
IR - Iran 1
JM - Giamaica 1
LT - Lituania 1
MD - Moldavia 1
MT - Malta 1
MY - Malesia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
OM - Oman 1
RO - Romania 1
SN - Senegal 1
TT - Trinidad e Tobago 1
Totale 7.577
Salva come PNG Salva come JPEG
Città #
Moscow 1.096
San Jose 272
Dublin 271
Singapore 258
Hong Kong 254
Santa Clara 213
Hefei 134
Dallas 111
Ho Chi Minh City 104
Seoul 101
Ashburn 100
Chandler 70
Hanoi 57
Munich 57
Beijing 51
Bengaluru 49
Naples 37
New York 34
Roxbury 34
Princeton 33
Cambridge 26
Los Angeles 26
The Dalles 25
São Paulo 23
Bremen 19
Da Nang 19
Jacksonville 19
Caserta 15
Medford 14
Ann Arbor 13
Orem 13
Boardman 12
Helsinki 12
Milan 11
Warsaw 11
Frankfurt am Main 10
Atlanta 9
Chicago 9
Falkenstein 9
Mexico City 9
Stockholm 9
Brussels 8
Des Moines 8
Rio de Janeiro 8
Rome 8
Tokyo 8
Brasília 7
Haiphong 7
Hải Dương 7
Toronto 7
Amsterdam 6
Baghdad 6
Boston 6
Grafing 6
Guangzhou 6
Lappeenranta 6
London 6
Pasadena 6
San Francisco 6
Turku 6
Bari 5
Biên Hòa 5
Brno 5
Buenos Aires 5
Buffalo 5
Bắc Ninh 5
Chennai 5
Curitiba 5
Hillsboro 5
Nuremberg 5
Phoenix 5
Porto Alegre 5
Redwood City 5
Thái Bình 5
Vienna 5
Viterbo 5
Wilmington 5
Ankara 4
Aversa 4
Brooklyn 4
Bến Tre 4
Can Tho 4
Changsha 4
Guarulhos 4
Houston 4
Huế 4
Montreal 4
Nanjing 4
Newark 4
Ninh Bình 4
Norwalk 4
Raleigh 4
Rockville 4
Tashkent 4
Zurich 4
Athens 3
Belgrade 3
Casablanca 3
City of London 3
Columbus 3
Totale 3.949
Salva come PNG Salva come JPEG
Nome #
Atypical Progressive Multifocal Leukoencephalopathy in a Kidney Transplant Recipient With Improving Symptoms After Immunocompetence Recovery 169
Telemedicine application to headache: a critical review 165
Dimethyl fumarate vs Teriflunomide: an Italian time-to-event data analysis 163
Alemtuzumab-Related Lymphocyte Subset Dynamics and Disease Activity or Autoimmune Adverse Events: Real-World Evidence 153
Lymphopenia in Multiple Sclerosis patients treated with Ocrelizumab is associated with an effect on CD8 T cells 148
Fake news, influencers and health-related professional participation on the Web: A pilot study on a social-network of people with Multiple Sclerosis 146
Disease Reactivation in Secondary Progressive Multiple Sclerosis Patients Switching from Fingolimod to Siponimod: A Case Series 144
Multiple sclerosis and genetic polymorphisms in fibrinogen-mediated hemostatic pathways: a case–control study 141
Exit Strategies in Natalizumab-Treated RRMS at High Risk of Progressive Multifocal Leukoencephalopathy: a Multicentre Comparison Study 136
Myasthenia gravis and telemedicine: a lesson from COVID-19 pandemic 136
Digital Health in Diabetes Care: A Narrative Review from Monitoring to the Management of Systemic and Neurologic Complications 135
Cd19 cell count at baseline predicts b cell repopulation at 6 and 12 months in multiple sclerosis patients treated with ocrelizumab 135
e-Health and multiple sclerosis: An update 134
BMI influences CD20 kinetics in multiple sclerosis patients treated with ocrelizumab 134
Assessment of Multiple Sclerosis Disability Progression Using a Wearable Biosensor: A Pilot Study 134
The effect of air pollution on COVID-19 severity in a sample of patients with multiple sclerosis 133
Association between relapses, stress, and depression in people with multiple sclerosis during the COVID-19 pandemic 132
Optimal retreatment schedule of rituximab for neuromyelitis optica spectrum disorder: A systematic review 131
Clinically Manifest Infections Do Not Increase the Relapse Risk in People with Multiple Sclerosis Treated with Disease-Modifying Therapies: A Prospective Study 130
Disability assessment using Google Maps 127
Health related quality of life in the domain of physical activity predicts confirmed disability progression in people with relapsing remitting multiple sclerosis 126
Telemedicine for management of patients with amyotrophic lateral sclerosis through COVID-19 tail 124
Signs and symptoms of COVID-19 in patients with multiple sclerosis 121
Right phrenic nerve palsy following transcatheter radiofrequency current atrial fibrillation ablation: Case report 119
Immunomodulatory effects of ocrelizumab and candidate biomarkers for monitoring treatment response in multiple sclerosis 119
ChatGPT vs. neurologists: a cross-sectional study investigating preference, satisfaction ratings and perceived empathy in responses among people living with multiple sclerosis 118
Social Media and Multiple Sclerosis in the Posttruth Age. 117
MRI and steroid-responsive encephalopathy associated with autoimmune thyroiditis: first report of conus medullaris involvement and literature review of the known neuroimaging profiles 114
The Use of Social Media and Digital Devices Among Italian Neurologists 113
Readability Analysis of Online Headache and Migraine Information 113
Digital work engagement among Italian neurologists 113
Association of vitamin D serum levels and vitamin D supplementation with B cell kinetics and disease activity in Multiple Sclerosis patients treated with ocrelizumab: an Italian multi-center study 113
Is It Time for Ocrelizumab Extended Interval Dosing in Relapsing Remitting MS? Evidence from An Italian Multicenter Experience During the COVID-19 Pandemic 112
Pain, quality of life, and religiosity in people with multiple sclerosis 109
Public engagement and neurology: An update 109
Viral pericarditis following ocrelizumab in a multiple sclerosis patient 108
How to manage with telemedicine people with neuromuscular diseases? 108
Hemostatic factors in the pathogenesis of neuroinflammation in multiple sclerosis 108
Behind the scenes: exploring neurological journal editors' work habits, decisions, and potential sources of conflict of interest 107
Digital therapeutics in neurology 107
Source of medical information and behavioral seeking patterns in patients affected with Friedreich’s ataxia and their caregivers: a survey study 107
Impact of early diagnosis on clinical characteristics of an Italian sample of people with multiple sclerosis recruited online. 105
Identifying definite patterns of unmet needs in patients with multiple sclerosis using unsupervised machine learning 104
Treatment of multiple sclerosis with rituximab: A multicentric Italian-Swiss experience 103
Editorial: Bridging the gap between basic neurosciences and clinical neuroimmunology 101
Heidenhain variant of Creutzefeldt-Jackob disease in a patient carrying the V210I mutation with asymmetric MRI abnormalities 101
Progressive multifocal leukoencephalopathy presenting with bilateral myoclonus: a case report 99
Real-world comparison of lymphopenia profiles in S1P receptor modulators for multiple sclerosis: a multicenter retrospective study 97
Understanding and managing the impact of the Covid-19 pandemic and lockdown on patients with multiple sclerosis 97
Ocrelizumab and ofatumumab comparison: an Italian real-world propensity score matched study 95
MRI activity and extended interval of Natalizumab dosing regimen: a multicentre Italian study 95
Hemostasis Components as Therapeutic Targets in Autoimmune Demyelination 95
Paraneoplastic syndrome or immune-related adverse event? A case of rhomboencephalitis in a patient treated with Pembrolizumab 94
Ocrelizumab Alters Cytotoxic Lymphocyte Function While Reducing EBV-Specific CD8 + T-Cell Proliferation in Patients With Multiple Sclerosis 86
First the B cells fall, then the T cells follow: temporal immunological shift with ocrelizumab in multiple sclerosis 85
Safety assessment of switching from fingolimod to siponimod: An Italian multicenter prospective study 85
Emotional facial palsy: an unusual and rarely explored neurological sign 84
Therapeutic choices and disease activity after 2 years of treatment with cladribine: An Italian multicenter study (CladStop) 83
Previous disease-modifying treatments influence T lymphocyte kinetics in people with multiple sclerosis switching to ocrelizumab 82
Glaucoma as a Tauopathy—Is It the Missing Piece in the Glaucoma Puzzle? 81
NEDA-3 achievement in early highly active relapsing remitting multiple sclerosis patients treated with Ocrelizumab or Natalizumab 80
Mapping Molecular Pathways of Multiple Sclerosis: A Gene Prioritization and Network Analysis of White Matter Pathology Transcriptomics 72
Modulation of NCX1 expression in monocytes associates with multiple sclerosis progression 71
Targeting shared pathways in tauopathies and age-related macular degeneration: implications for novel therapies 71
Reply to Wostyn, P. Targeting the Cerebrospinal Fluid Compartment in Glaucoma: Still the Dark Side of the Moon? Comment on “Passaro et al. Glaucoma as a Tauopathy—Is It the Missing Piece in the Glaucoma Puzzle? J. Clin. Med. 2023, 12, 6900” 70
Sexual dysfunction in multiple sclerosis: The impact of different MSISQ-19 cut-offs on prevalence and associated risk factors 70
Sexual Dysfunction in People with Multiple Sclerosis: The Role of Disease Severity, Illness Perception, and Depression 70
MicroRNA-142-3p shuttling in extracellular vesicles marks regulatory T cell dysfunction in multiple sclerosis 68
Long-Term Effectiveness and Safety of Rituximab in Neuromyelitis Optica Spectrum Disorder: A 5-Year Observational Study 67
Plasma microRNA Signature as Predictive Marker of Clinical Response to Therapy During Multiple Sclerosis 57
ANTI-CD20 AGENTS RESHAPE THE PHENOTYPE AND FUNCTIONS OF CYTOTOXIC LYMPHOCYTES AND SELECTIVELY MITIGATE EBV-SPECIFIC CD8+ T CELL REACTIVITY IN PEOPLE WITH RELAPSING MULTIPLE SCLEROSIS 11
Totale 7.690
Salva come PNG Salva come JPEG
Categoria #
all - tutte 24.490
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.490
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202125 0 0 0 0 0 0 0 0 0 4 12 9
2021/2022240 2 15 4 5 60 15 2 3 17 6 23 88
2022/2023416 63 12 9 11 35 18 2 11 222 6 11 16
2023/2024297 16 11 22 13 79 39 13 5 7 4 11 77
2024/20251.150 2 12 10 75 180 114 145 98 198 98 128 90
2025/20265.417 220 382 387 228 486 2.798 330 287 204 95 0 0
Totale 7.690